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 Abstract 
 Background: Evidence-based medicine (EbM) is a vital part of reasonable and conclusive de-
cision making for clinicians in daily clinical work. To analyze the knowledge and the attitude 
of surgeons towards EbM, a survey was performed in the UK and Germany.  Methods: A web-
based questionnaire was distributed via mailing lists from the Royal College of Surgeons of 
England (RCSE) and the Berufsverband Deutscher Chirurgen (BDC). Our primary aim was to 
get information about knowledge of EbM amongst German and British surgeons.  Results:  A 
total of 549 individuals opened the questionnaire, but only 198 questionnaires were complete 
and valid for analysis. In total, 40,000 recipients were approached via the mailing lists of the 
BDC and RCSE. The response rate was equally low in both countries. On a scale from 1 (unim-
portant) to 10 (very important), all participants rated EbM as very important for daily clinical 
decision making (7.3 ± 1.9) as well as for patients (7.8 ± 1.9) and the national health system 
(7.8 ± 1.9). On a scale from 1 (unimportant) to 5 (very important), systematic reviews (4.6 ± 
0.6) and randomized controlled trials (4.6 ± 0.6) were identified as the highest levels of study 
designs to enhance evidence in medicine. British surgeons considered EbM to be more im-
portant in daily clinical work when compared to data from German surgeons (7.9 ± 1.6 vs. 6.7 
± 2.1, p < 0.001). Subgroup analysis showed different results in some categories; however, a 
pattern to explain the differences was not evident. Personal requirements expressed in a free 
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text field emphasized the results and reflected concerns such as broad unwillingness and lack 
of interdisciplinary approaches for patients (n = 59: 25 in the UK and 34 in Germany).  Conclu-
sion: The overall results show that EbM is believed to be important by surgeons in the UK and 
Germany. However, perception of EbM in the respective health system (UK vs. Germany) may 
be different. Nonetheless, EbM is an important tool to navigate through daily clinical prob-
lems although a discrepancy between the knowledge of theoretical abstract terms and dif-
ficulties in implementing EbM in daily clinical work has been detected. The provision of infra-
structure, courses and structured education as a permanent instrument will advance the 
knowledge, application and improvement of EbM in the future.  © 2014 S. Karger AG, Basel 
 Introduction 
 Evidence-based medicine (EbM) has been described by Rosenberg and Donald  [1]  in 
1995 as a ‘process of systematically finding, appraising, and using contemporaneous research 
findings as the basis for clinical decisions’. Sackett and colleagues  [2, 3] defined what evidence 
is and what it is not by proposing five specific rules: ‘firstly, clinical decisions should be based 
on the best available scientific evidence; secondly, the clinical problem – rather than habits 
or protocols – should determine the type of evidence to be sought; thirdly, identifying the best 
evidence means using epidemiological and bio-statistical ways of thinking; fourthly, conclu-
sions derived from identifying and critically appraising evidence are useful only if put into 
action in managing patients or making health care decisions, and, finally, performance should 
be constantly evaluated’. 
 This definition attempts to put every individual patient in the focus of decision making 
by utilizing the best evidence present, and respects individualization and tailoring. None-
theless, while substantial use of EbM is readily apparent, the daily clinical behavior of surgeons 
concerning EbM is not well analyzed  [4, 5] . This is particularly relevant to surgery since tech-
nical developments and their clinical application often outpace the aspiration for testing its 
validity in daily clinical use  [6] . 
 In December 2011, the question of how surgeons can be convinced to follow results from 
high-quality evidence-based studies in surgery was raised after a presentation on improving 
evidence in abdominal and transplant surgery. An idea was proposed to gather information 
from surgeons about their basic knowledge of EbM in general, and specifically by means of an 
example from daily surgical care. We developed 5-min surveys including 16 questions, which 
collected demographic data and included questions and examples relevant to a surgical 
setting. 
 To gain a better understanding of how EbM can be better transferred and integrated into 
daily clinical surgical practice, we performed the survey in the UK and Germany to receive 
views from two different health care systems. Our primary aim was to get an insight into the 
surgeons’ basic knowledge of EbM and, moreover, to determine if there are differences in 
knowledge between British and German surgeons.
 Methods 
 Online Survey, Review and Cooperation 
 An online survey was generated in German and English which is available at www.q-set.de. The survey 
was sent to the Centre for Evidence in Transplantation for review and critical analysis of the contents. Finally, 
the Berufsverband Deutscher Chirurgen (BDC) and the Royal College of Surgeons of England (RCSE) agreed 
to post the survey on their respective homepages and distribute the online link via their mailing list in their 
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periodic online newsletters. The survey was launched online on May 15, 2012, with a reminder being sent to 
members in September 2012; the database was finally closed on December 1, 2012. Demographic data 
(gender, age, position, supply level of hospital) were collected in the first four questions. Then, the relevance 
of EbM regarding daily work, the national health system and patients was raised. Knowledge of EbM was 
tested by asking questions about a common clinical procedure, namely laparoscopic cholecystectomy. 
Moreover, knowledge about different tools of EbM or providing evidence in medicine, such as databases or 
quality of studies, was retrieved from participants. Finally, participants could express their wishes and 
requirements to improve knowledge in EbM.
 Statistics 
 Statistical analyses were performed using Sigma Stat 11.0 (Systat Software Inc., Richmond, Calif., USA) . 
Data are given as means with standard deviation, and the median with minimum and maximum was calcu-
lated. T tests were performed to detect significant differences between groups. A p value <0.05 was regarded 
to reflect statistically significant differences.
 Results 
 Response Rate 
 The mailing lists of the BDC and the RCSE contained approximately 40,000 e-mails. Both 
institutions estimated that the e-mails would typically be opened by approximately 30% of 
the recipients. Then, we estimated that approximately 50% would read the newsletter. The 
survey was announced on the first page and was highlighted to attract a high number of 
readers. Finally, a total of 549 questionnaires were opened via the link provided in the news-
Newsletter distributed to
BDC and RCSE
members via e-mail
Approximately 40,000 recipients
Estimated number of
opened e-mails
Approximately 12,000 
Estimated number of
read e-mails
Approximately 6,000 
Questionnaires opened
n = 549
Complete data
valid for analysis
n = 198
Incomplete data
n = 79
No data entered
n = 272
 Fig. 1. Flowchart explaining the response rate. 
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letter, but only 198 questionnaires were completed and valid for analysis.  Figure 1 depicts a 
response rate flow chart for the survey.
 Gender, Age, Position and Service Level 
 Table 1 gives an overview of the participants’ gender, age, and position and the service 
level of both countries. Importantly, there were similar numbers of completed questionnaires 
collected from Germany (n = 102) and the UK (n = 96).
 Overall Results 
 All participants rated the usefulness of EbM in their daily clinical work with a mean of 7.3 
± 1.9 points (range: 1 = unimportant to 10 = very important). The usefulness of the EbM for 
the national health system and for patients was given 7.8 ± 1.9 points. Based on a clinically 
relevant example, the participants were asked to give their opinion as to why laparoscopic 
cholecystectomy is considered as the standard technique. They had to validate the following 
statements: (1) laparoscopic cholecystectomy is safer than the open technique (4.0 ± 2.5 
points), (2) patients ask for it (6.8 ± 2.6 points), and (3) it is more cost-effective for the health 
system (5.6 ± 2.8 points); the answer could be valued from 1 (wrong) to 10 (correct). Finally, 
the participants were asked about which study designs expand evidence in medicine signifi-
cantly. The highest ratings were obtained for systematic reviews and meta-analyses (4.6 ± 0.6 
points), randomized controlled trials (RCTs; 4.5 ± 0.6 points) and systematic reviews of 
Table 1.  Participants’ overview
Categories UK 
(n = 96)
Germany
(n = 102)
Total
(n = 198)
Gender female 19 (20) 24 (24) 43 (22)
mal e 77 (80) 78 (76) 155 (78)
subtotal 96 102 198
Age 25 – 30 years 8 (8) 19 (19) 27 (14)
31 – 35 years 17 (18) 13 (13) 30 (15)
36 – 40 years 10 (10) 23 (23) 33 (17)
41 – 50 years 19 (20) 25 (25) 44 (22)
>50 years 42 (44) 22 (21) 64 (32)
subtotal 96 102 198
Position resident 18 (19) 32 (31) 40 (20)
fellow 11 (11) 18 (18) 29 (15)
consultant 51 (53) 29 (28) 80 (40)
director/head of program or clinic 7 (7) 15 (15)0 22 (11)0
other 9 (9) 8 (8) 17 (9)
subtotal 96 102 198
Service level basic supply 1 (1) 17 (17) 18 (9)
secondary hospital 47 (49) 24 (24) 71 (36)
tertiary referral hospital (highly specialized 
and university clinics) 48 (50) 61 (60)0 109 (55)
 Values in parentheses are percentages. For Germany, positions and service levels have been transferred 
as approximation: resident = Arzt in Weiterbildung; fellow = Facharzt; consultant = Oberarzt; director/head 
of program or clinic = Chefarzt; basic supply = Grund- und Regelversorgung; secondary hospital = Schwer-
punktversorgung; tertiary referral hospital = Maximalversorgung.
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cohort studies (3.6 ± 0.8 points). The answer’s importance could be valued from 1 (unim-
portant) to 5 (very important).
 Comparing EbM in the UK and Germany 
 For the secondary analysis, the results from the participants in the UK (n = 96) and 
Germany (n = 102) were compared ( table 2 ). Significantly, more British surgeons thought 
that EbM was very useful in daily clinical work compared to German surgeons (7.9 ± 1.6 vs. 
6.7 ± 2.1, p < 0.001). Additionally, there were completely different viewpoints concerning 
safety, patient preference and cost-effectiveness of laparoscopic cholecystectomy compared 
to open interventions. On a scale from 0 to 10, British (vs. German) surgeons more strongly 
believed that laparoscopic cholecystectomy is the standard surgical procedure because it is 
safer (4.9 ± 2.3 vs. 3.2 ± 2.4, p < 0.001) and more cost-effective (6.7 ± 2.4 vs. 4.6 ± 2.9, p < 
0.001). In contrast, German (vs. British) surgeons more strongly believed that laparoscopic 
cholecystectomy is the standard procedure because patients ask for it (5.8 ± 2.5 vs. 7.7 ± 2.3, 
p < 0.001). There were very minor but significant differences regarding the study designs that 
are considered to significantly expand evidence ( table 2 ). 
 EbM Comparing Different Ages, Gender, Positions and Service Levels  
 Subgroup analyses were performed to explore the detected differences in a more detailed 
manner. However, the results were nearly the same throughout all analyzed British and 
German subgroups for age, gender, position and supply level (secondary vs. tertiary) of the 
hospital (data not shown). Analysis of combined subgroups from both countries (female vs. 
male,  ≤ 40 vs. >40 years, in education vs. leaders, basic/secondary supply vs. tertiary supply) 
revealed the largest differences for surgeons working in basic and secondary supply hospitals 
when compared to surgeons in tertiary supply hospitals. Here, 7 of 13 questions that were 
Table 2.  Comparison of the British and German surgeons’ opinions regarding the utility of EbM, the role of laparoscopic chole-
cystectomy representing a daily clinically relevant example, and the role of study quality in increasing evidence in medicine
UK (n = 96)  Germany (n = 102) p 
valuemean ± SD median range me an ± SD median range
How would you rate the utility of EbM …a 
... regarding daily work? 7.9 ± 1.6 8 3 – 10 6.7 ± 2.1 8 1 – 10 <0.001
... regarding the national health system? 7.8 ± 1.9 8 2 – 10 7.4 ± 2.1 8 1 – 10 0.255
... for patients? 8.1 ± 1.6 8 2 – 10 7.5 ± 2.0 8 1 – 10 0.065
Laparoscopic cholecystectomy is today’s standard surgical procedure because …b
... it is safer 4.9 ± 2.3
5.8 ± 2.5
5 1 – 10 3.2 ± 2.4
 7.7 ± 2.3
5 1 – 9 <0.001
... patients ask for it 5 1 – 10 5 1 – 10 <0.001
... it is more cost-effective 6.7 ± 2.4 7 1 – 10 4.6 ± 2.9 7 1 – 10 <0.001
Which types of studies expand evidence in medicine significantly?c
 Meta-analyses 4.6 ± 0.6
4.4 ± 0.6
3.7 ± 0.7
2.9 ± 0.8
2.9 ± 0.8
2.4 ± 1.0
2.5 ± 1.2
5 2 – 5 4.5 ± 0.6
4.6 ± 0.5
3.4 ± 0.8
2.7 ± 0.8
2.7 ± 1.0
2.2 ± 1.0
2.3 ± 1.1
5 2 – 5 0.56
RCTs
Systematic reviews
Individual cohort studies
Case control studies
Case series
Expert opinions
4
4
3
3
2
2
3 – 5
2 – 5
1 – 5
1 – 5
1 – 5
1 – 5
4
4
3
3
2
2
3 – 5
1 – 5
1 – 5
1 – 5
1 – 5
1 – 5
0.01
0.001
0.016
0.161
0.092
0.182
 a 1 = unimportant, 10 = very important; b 1 = wrong, 10 = correct; c 1 = unimportant, 5 = very important.
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asked revealed significant differences ( table 3 ). Both, the participants from basic supply 
hospital as well as the participants from secondary/tertiary supply hospitals rated EbM with 
the same importance for daily work, patients and the national health systems. Views on safety, 
patient preferences and cost-effectiveness of laparoscopic cholecystectomies, however, 
differed significantly. Moreover, their perception of study quality importance regarding the 
influence on generating evidence was significantly different.
 Personal Requirements and Worries of Surgeons Concerning EbM 
 Free text fields at the end of the survey were available for the participants to express their 
personal concerns and requirements concerning a reasonable and successful application of 
EbM. A total of 172 answers were received, 86 from Germany and 86 from the UK. There were 
various, though similar comments, from both German and British surgeons. Some partici-
pants gave multiple comments. Many expressed their concern that hierarchies in hospitals 
are still too strict. They also expressed their concern that teaching in EbM is still not adequate 
during surgical training. Additionally, there is a broad unwillingness and lack of interdisci-
plinary approaches for patients (n = 59: 25 in the UK and 34 in Germany). Time (n = 31) and 
financial aspects (n = 20) were also identified as critical factors, which included lack of time 
for reading and literature research as well as workload in the clinic combined with adminis-
trative pressure. Lack of evidence for interventions (n = 14), lack of guidelines (n = 5), political 
reasons (n = 6), overload of sources, such as search tools and databases (n = 7), and patient 
preferences for a specific therapy (n = 4) were less frequently mentioned. A total of 23 partic-
ipants did not mention any concerns. Finally, 15 participants explained that there is often a 
lack of EbM and that individualized therapies for patients are performed without established 
guidelines.
 Participant Requirements 
 Finally, there was a broad consensus amongst the participants that more teaching of EbM 
in the form of special congress topics, online information and continuing medical education 
is absolutely necessary to establish and deepen knowledge of this issue in surgery.
Table 3.  Comparison of demographic subgroups regarding the utility of EbM, the role of laparoscopic cholecystectomy repre-
senting a daily clinically relevant example, and the value of study quality to increase evidence in medicine
Female
(n = 43) 
Male
(n = 155)
p 
value
≤40 years
(n = 90)
>40 years 
(n = 108)
p 
value
Trainees
(n = 79)
Consultants 
(n = 102)
p 
value
Basic/
secondary
(n = 89) 
Tertiary 
hospitals 
(n = 109)
p 
value
How would you rate the utility of EbM ...a 
... regarding daily work? 7 (3 – 10) 8 (1 – 10) 0.333 7 (1 – 10) 8 (3 – 10) 0.088 7 (1 – 10) 8 (3 – 10) 0.009 8 (1 – 10) 8 (3 – 10) 0.662
... regarding the national
health system? 9 (3 – 10) 8 (1 – 10) 0.033 8 (1 – 10) 8 (1 – 10) 0.062 8 (1 – 10) 8 (3 – 10) 0.466 8 (1 – 10) 8 (2 – 10) 0.443
... for patients? 9 (3 – 10) 8 (1 – 10) 0.086 8 (1 – 10) 8 (3 – 10) 0.336 8 (1 – 10) 8 (1 – 10) 0.576 8 (1 – 10) 8 (1 – 10) 0.464
Laparoscopic cholecystectomy is today’s standard surgical procedure because …b
... it is safer 4 (1 – 9) 4 (1 – 10) 0.546 4 (1 – 10) 4 (1 –  10) 0.203 3 (1 – 10) 4 (1 – 10) 0.544 4 (1 – 10) 2 (1 – 9) 0.002
... patients ask for it 7 (1 – 10) 8 (1 – 10) 0.05 8 (1 – 10) 7 (1 – 10) 0.553 7 (1 – 10) 7 (1 – 10) 0.914 7 (1 – 10) 8 (1 – 10) 0.011
... it is more cost-effective 6 (1 – 10) 5 (1 – 10) 0.212 5 (1 – 10) 5 (1 – 10) 0.780 6 (1 – 10) 5 (1 – 10) 0.344 5 (1 – 10) 4 (1 – 10) 0.009
Which types of studies expand evidence in medicine significantly?c
Meta-analyses 5 (2 – 5) 5 (2 – 5) 0.454 5 (2 – 5) 5 (2 – 5) 0.049 5 (2 – 5) 5 (2 – 5) 0.037 5 (2 – 5) 5 (2 – 5) 0.550
RCTs 5 (3 – 5) 5 (3 – 5) 0.282 5 (3 – 5) 4 (3 – 5) 0.003 5 (3 – 5) 4 (3 – 5) 0.028 4 (3 – 5) 5 (3 – 5) 0.001
Systematic reviews 3 (1 – 4) 4 (1 – 5) 0.249 4 (1 – 5) 4 (1 – 5) 0.425 4 (1 – 5) 4 (2 – 5) 0.523 4 (1 – 5) 3 (1 – 5) 0.112
Individual cohort studies 3 (1 – 4) 3 (1 – 5) 0.921 3 (1 – 5) 3 (1 – 4) 0.699 3 (1 – 5) 3 (1 – 4) 0.495 3 (1 – 4) 3 (1 – 5) 0.024
Case control studies 3 (1 – 5) 3 (1 – 5) 0.370 3 (1 – 5) 3 (1 – 5) 0.435 3 (1 – 5) 3 (1 – 4) 0.324 3 (1 – 5) 2 (1 – 4) <0.001
Case series 2 (1 – 4) 2 (1 – 5) 0.495 2 (1 – 5) 2 (1 – 5) 0.247 2 (1 – 5) 2 (1 – 4) 0.996 2 (1 – 5) 2 (1 – 5) 0.005
Expert opinions 2 (1 – 5) 2 (1 – 5) 0.355 2 (1 – 5) 3 (1 – 5) 0.038 2 (1 – 5) 2 (1 – 5) 0.165 3 (1 – 5) 2 (1 – 4) 0.062
 Values are given as medians (min. to max.). a 1 = unimportant, 10 = very important; b 1 = wrong, 10 = correct; c 1 = unimportant, 5 = very important.
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
ts
bi
bl
io
th
ek
, R
eg
en
sb
ur
g
13
2.
19
9.
19
9.
23
0 
- 8
/2
8/
20
18
 3
:1
7:
09
 P
M
20Eur Surg Res 2015;54:14–23
 DOI: 10.1159/000367940 
 Schnitzbauer et al.: Evidence-Based Medicine in Daily Surgical Decision Making: A 
Survey-Based Comparison between the UK and Germany 
www.karger.com/esr
© 2014 S. Karger AG, Basel
 Discussion 
 EbM is recognized as a very important subject amongst surgeons in Germany and the UK. 
The median rating of surgeons concerning the utility of EbM for daily work decisions, the 
national health system and for patients was high. Moreover, the participants adequately rated 
the study designs that provide higher levels of evidence. However, it continues to be an 
abstract field which although recognized as important is not always used in daily clinical 
practice  [6] . For instance, there was a common discrepancy between existing evidence and a 
long practiced experience by senior surgeons, evident in our survey through raised concerns 
(30% of the participants) in the open comment section.
 Although perceptions of EbM deliver high scores and quite similar results for both British 
and German surgeons, the clinical example of the utility of laparoscopic cholecystectomy 
revealed a somewhat different perception, representing one of the most commonly performed 
procedures worldwide. More specifically, British surgeons in comparison to German surgeons 
were of the opinion that laparoscopic cholecystectomy is safer than open cholecystectomy. 
Literature research identified three meta-analyses from the Cochrane database where open 
cholecystectomy and mini-incision cholecystectomy are compared to laparoscopic cholecys-
tectomy  [7–9] . There were no differences when comparing safety, in terms of the compli-
cation rates, between the open and laparoscopic techniques. However, it is interesting that 
complication rates were higher in high-quality RCTs (17%) compared to retrospective cohort 
studies (5%). Laparoscopic cholecystectomy is associated with a faster recovery and discharge 
of patients. Whilst the costs for surgery alone are higher for laparoscopic cholecystectomy, 
some authors argue that the overall costs to the health care and economic systems are reduced 
by shorter clinic stays that lead in many cases to patients returning back to work faster  [7–17] . 
Regarding patient preferences, there is no evidence in the literature that patients ask their 
surgeon for laparoscopic surgery. Therefore, the existing evidence shows no surgical superi-
ority of laparoscopic cholecystectomy in terms of safety. The evidence supporting laparo-
scopic cholecystectomy is related to the shorter postoperative clinical course but not to the 
surgeon’s beliefs regarding patient preference. 
 Personal comments at the end of the survey helped to expand opinions restricted by the 
categories selected in the survey. Participants used various arguments to express their 
requirements and restrictions associated with EbM involvement. Reasons highlighted for 
rejecting EbM included strict hierarchies, lack of EbM training, missing interdisciplinary 
approaches, time, absence of financial means, lack of evidence and guidelines, and resource 
overload (e.g. search tools or databases). 
 This leads to the discussion of possible solutions. First and foremost, the integration of 
EbM in education must be constant from the early days of medical school to daily clinical work 
in every particular field of surgery. A good example of the integration of EbM in societies is 
the syllabus for different certified surgical examinations for the European Union of Medical 
Specialists of Surgery and European Board of Surgery. One of the requirements is the ability 
to interpret and analyze data from a variety of papers provided for the examination. Secondly, 
certification of centers for a special focus, such as pancreas, colorectal, or endocrine cancer 
promotes interdisciplinary approaches, typically through transparent case evaluation boards 
that pool current evidence  [18–20] . Thirdly, the scientific infrastructure of surgical societies 
should be improved. For instance, in Germany, the German Surgical Society (DGCH) supports 
and funds a study center in Heidelberg charged with the task of developing and conducting 
clinical trials in surgery  [4, 5, 21, 22] . Fourthly, access to high-level evidence for busy clini-
cians should be facilitated. To this end, the Centre for Evidence in Transplantation (www.
transplantevidence.com) has established the Transplant Library – a specialist database of all 
RCTs and good-quality systematic reviews in solid organ transplantation  [23] . The Library 
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can be used without professional search skills and gives quick and easy access to high-level 
evidence. 
 Comments from the respondents raised the issue whether a critical review of established 
surgical procedures that have been successfully applied for more than 150 years is needed. 
In general, while challenging these basic methods is perhaps futile, single aspects of certain 
surgical procedures or treatments can expose clinical insecurities and should therefore be 
clarified by randomized clinical trials. Thus, a categorization of surgical techniques and the 
relevance to explore more evidence might be helpful: (i) classic surgical techniques that have 
been described in textbooks should be regarded as the standard treatment of care; (ii) 
contemporary surgical innovations should be regarded as the standard treatment of care 
today (e.g. laparoscopic cholecystectomy, continuously evolving surgical techniques, and 
natural orifice transluminal endoscopic surgery, single incision laparoscopic surgery or asso-
ciating liver partition with portal vein ligation for staged hepatectomy in liver resection  [24] ); 
(iii) diseases with a lack of guidelines refer to standard treatments and classifications that 
exist without sufficient and convincing evidence from clinical trials (e.g. sigmoid diverticu-
litis, suture or stapling of loop ileostomy closure, clipping or sutures in thyroid surgery, 
immunosuppression in patients with renal impairment or hepatocellular carcinoma after 
liver transplantation  [25–33] ), and (iv) complex treatment decisions in interdisciplinary 
oncologic settings that still reveal clinical insecurity and need clarification with clinical trials 
(e.g. neoadjuvant and adjuvant therapy strategies in colorectal liver metastases), but also 
warrant an individualized and tailored therapy.
 A major limitation of our study is the low response rate to the survey. Although distributed 
and announced via two major professional societies highlighting the survey in their regular 
newsletter, the response rate was low. This may be a problem regarding internet-based 
surveys in general, since the request to participate is not made personally to every single 
person and potential participants are overloaded with requests to participate in surveys. The 
results in this survey may be prone to some bias because persons with a positive view of EbM 
may have been more likely to participate. Nonetheless, opinion polls in political discussions 
face similar hurdles but do tend to deliver fairly exact pictures with small polling numbers. If 
we are sincere in our efforts to improve EbM, more academic surgeons should feel obligated 
to participate in such efforts. 
 In conclusion, our survey indicates that EbM is seen as an important tool to navigate 
through daily clinical insecurities. However, surgeons often underutilize structured state-of-
the-art evidence resources. Efforts need to be intensified to properly mentor involved surgical 
personnel through local programs and structured education systems. National study centers 
like the Study Centre of the DGCH in Heidelberg are also an instrument to foster and establish 
a culture of medicine on the highest level of obtainable evidence. 
 Acknowledgements 
 We deeply thank all participants in the UK and Germany for filling out the questionnaire and for their 
very personal comments that helped us to unveil the requirements in surgery-related EbM in both countries. 
Additionally, we thank Marius Müller for providing the national platform in the UK for the distribution of the 
e-mails. Peter Morris functioned as adviser in the development of the questionnaire.
 Disclosure Statement 
 The authors have no conflicts of interest to disclose.
 
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
ts
bi
bl
io
th
ek
, R
eg
en
sb
ur
g
13
2.
19
9.
19
9.
23
0 
- 8
/2
8/
20
18
 3
:1
7:
09
 P
M
22Eur Surg Res 2015;54:14–23
 DOI: 10.1159/000367940 
 Schnitzbauer et al.: Evidence-Based Medicine in Daily Surgical Decision Making: A 
Survey-Based Comparison between the UK and Germany 
www.karger.com/esr
© 2014 S. Karger AG, Basel
 References 
  1 Rosenberg W, Donald A: Evidence based medicine: an approach to clinical problem-solving. BMJ 1995; 310: 
 1122–1126.  
  2 Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS: Evidence based medicine: what it is and what 
it isn’t. BMJ 1996; 312: 71–72.  
  3 Davidoff F, Haynes B, Sackett D, Smith R: Evidence based medicine. BMJ 1995; 310: 1085–1086.  
  4 Diener MK, Knebel P, Fink C, Dörr-Harim C, Rossion I, Werner J, et al: Clinical trials in surgery. On the way 
towards evidence-based surgery (in German). Chirurg 2012; 83: 315–318.  
  5 Diener MK, Wolff RF, von Elm E, Rahbari NN, Mavergames C, Knaebel H-P, et al: Can decision making in general 
surgery be based on evidence? An empirical study of Cochrane Reviews. Surgery 2009; 146: 444–461.  
  6 Schwenk W, Haase O, Müller JM: Changing surgical therapy because of clinical studies? (in German). Zentralbl 
Chir 2002; 127: 258–264.  
  7 Keus F, de Jong JAF, Gooszen HG, van Laarhoven CJHM: Laparoscopic versus open cholecystectomy for patients 
with symptomatic cholecystolithiasis. Cochrane Database Syst Rev 2006; 4:CD006231.  
  8 Keus F, de Jong JAF, Gooszen HG, van Laarhoven CJHM: Laparoscopic versus small-incision cholecystectomy 
for patients with symptomatic cholecystolithiasis. Cochrane Database Syst Rev 2006; 4:CD006229.  
  9 Keus F, Gooszen HG, van Laarhoven CJ: Open, small-incision, or laparoscopic cholecystectomy for patients 
with symptomatic cholecystolithiasis. An overview of Cochrane Hepato-Biliary Group reviews. Cochrane 
Database Syst Rev 2010; 1:CD008318.  
 10 Barkun AN, Barkun JS, Sampalis JS, Caro J, Fried GM, Meakins JL, et al: Costs and effectiveness of extracorporeal 
gallbladder stone shock wave lithotripsy versus laparoscopic cholecystectomy. A randomized clinical trial. 
McGill Gallstone Treatment Group. Int J Technol Assess Health Care 1997; 13: 589–601.  
 11 Bass EB, Pitt HA, Lillemoe KD: Cost-effectiveness of laparoscopic cholecystectomy versus open cholecys-
tectomy. Am J Surg 1993; 165: 466–471.  
 12 Bosch F, Wehrman U, Saeger H-D, Kirch W: Laparoscopic or open conventional cholecystectomy: clinical and 
economic considerations. Eur J Surg Acta Chir 2002; 168: 270–277.  
 13 Fajardo R, Valenzuela JI, Olaya SC, Quintero G, Carrasquilla G, Pinzón CE, et al: Cost-effectiveness of laparo-
scopic versus open cholecystectomy (in Spanish). Biomedica 2011; 31: 514–524.  
 14 Fullarton GM, Darling K, Williams J, MacMillan R, Bell G: Evaluation of the cost of laparoscopic and open chole-
cystectomy. Br J Surg 1994; 81: 124–126.  
 15 Kelley JE, Burrus RG, Burns RP, Graham LD, Chandler KE: Safety, efficacy, cost, and morbidity of laparoscopic 
versus open cholecystectomy: a prospective analysis of 228 consecutive patients. Am Surg 1993; 59: 23–27.  
 16 Keskin A: Is laparoscopic cholecystectomy cheaper? Surg Laparosc Endosc Percutan Tech 2005; 15: 191–194; 
discussion 194.  
 17 Kesteloot K, Penninckx F: The costs and effects of open versus laparoscopic cholecystectomies. Health Econ 
1993; 2: 303–312.  
 18 Keating NL, Landrum MB, Lamont EB, Bozeman SR, Shulman LN, McNeil BJ: Tumor boards and the quality of 
cancer care. J Natl Cancer Inst 2013; 105: 113–121.  
 19 Bell RH: National curricula, certification and credentialing. Surgeon 2011; 9(suppl 1):S10–S11.  
 20 Weikert S, Baumunk D, Stephan C, Cash H, Jahnke K, Steiner U, et al: Introduction of interdisciplinary prostate 
cancer centers based on the recommendations of the German Cancer Society. A cost-benefit analysis 3 years 
after accreditation (in German). Urologe A 2011; 50: 1083–1088.  
 21 Fink C, Keck T, Rossion I, Weitz J, Diener MK, Büchler MW, et al: Contribution of the Study Center of the German 
Surgical Society to evidence based surgery (in German). Chirurg 2011; 82: 1109–1115.  
 22 Schiessling S, Diener MK, Post S, Büchler MW, Seiler CM: Clinical trials in surgery – health care research of the 
future? (in German). Zentralbl Chir 2011; 136: 87–89.  
 23 Pengel L, Morris P: The transplant library of randomized controlled trials and systematic reviews. Transplan-
tation 2011; 92: 613–616.  
 24 Schnitzbauer AA, Lang SA, Goessmann H, Nadalin S, Baumgart J, Farkas SA, et al: Right portal vein ligation 
combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended 
right hepatic resection in small-for-size settings. Ann Surg 2012; 255: 405–414.  
 25 Hackert T, Bruckner T, Dörr-Harim C, Diener MK, Knebel P, Hartwig W, et al: Pylorus resection or pylorus 
preservation in partial pancreatico-duodenectomy (PROPP study): study protocol for a randomized controlled 
trial. Trials 2013; 14: 44.  
 26 Löffler T, Rossion I, Bruckner T, Diener MK, Koch M, von Frankenberg M, et al: HAnd Suture Versus STApling 
for Closure of Loop Ileostomy (HASTA Trial): results of a multicenter randomized trial (DRKS00000040). Ann 
Surg 2012; 256: 828–835; discussion 835–836.  
 27 Diener MK, Seiler CM, von Frankenberg M, Rendel K, Schüle S, Maschuw K, et al: Vascular clips versus ligatures 
in thyroid surgery – results of a multicenter randomized controlled trial (CLIVIT Trial). Langenbecks Arch 
Surg 2012; 397: 1117–1126.  
 28 Schnitzbauer AA, Schlitt HJ, Geissler EK: Influence of immunosuppressive drugs on the recurrence of hepato-
cellular carcinoma after liver transplantation: a gap between basic science and clinical evidence. Transplan-
tation 2011; 91: 1173–1176.  
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
ts
bi
bl
io
th
ek
, R
eg
en
sb
ur
g
13
2.
19
9.
19
9.
23
0 
- 8
/2
8/
20
18
 3
:1
7:
09
 P
M
23Eur Surg Res 2015;54:14–23
 DOI: 10.1159/000367940 
 Schnitzbauer et al.: Evidence-Based Medicine in Daily Surgical Decision Making: A 
Survey-Based Comparison between the UK and Germany 
www.karger.com/esr
© 2014 S. Karger AG, Basel
 29 Schnitzbauer AA, Doenecke A, Sothmann JL, Loss M, Farkas SA, Hartl J, et al: Improved outcome after ‘bottom-
up’ immunosuppression in liver transplant recipients with preoperative renal impairment. Eur Surg Res 
2010; 45: 356–367.  
 30 Schnitzbauer AA, Scherer MN, Rochon J, Sothmann J, Farkas SA, Loss M, et al: Study protocol: a pilot study to 
determine the safety and efficacy of induction-therapy, de novo MPA and delayed mTOR-inhibition in liver 
transplant recipients with impaired renal function. PATRON-study. BMC Nephrol 2010; 11: 24.  
 31 Schnitzbauer AA, Zuelke C, Graeb C, Rochon J, Bilbao I, Burra P, et al: A prospective randomised, open-labeled, 
trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients under-
going liver transplantation for hepatocellular carcinoma. BMC Cancer 2010; 10: 190.  
 32 Glockzin G, Rochon J, Arnold D, Lang SA, Klebl F, Zeman F, et al: A prospective multicenter phase II study eval-
uating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and 
colorectal cancer: the COMBATAC trial. BMC Cancer 2013; 13: 67.  
 33 Stein A, Glockzin G, Wienke A, Arnold D, Edelmann T, Hildebrandt B, et al: Treatment with bevacizumab and 
FOLFOXIRI in patients with advanced colorectal cancer: presentation of two novel trials (CHARTA and 
PERIMAX) and review of the literature. BMC Cancer 2012; 12: 356.  
 
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
ts
bi
bl
io
th
ek
, R
eg
en
sb
ur
g
13
2.
19
9.
19
9.
23
0 
- 8
/2
8/
20
18
 3
:1
7:
09
 P
M
